Heavy!The first domestic anti -new crown oral medication was approved for listing
Author:Henan Metropolis Channel Time:2022.07.26
On July 25, the State Drug Administration conducted emergency review and approval in accordance with the relevant provisions of the Drug Management Law in accordance with the relevant provisions of the Drug Management Law.Symptom registration application.
This product is the treatment of oral small molecular virus pneumonia for oral small molecular virus pneumonia in my country.On July 20, 2021, the State Drug Administration has attached conditions to approve this product and other reverse-translitease inhibitors to treat adult HIV-1 infection patients with high virus load.This is an attachment to approve new indications for the treatment of adult patients with COVID-19) for the treatment of ordinary new type of coronary virus pneumonia.Patients should be used strictly under the guidance of the doctor.
The State Drug Administration requires listing permit holders to continue to carry out relevant research work, complete the requirements for qualified conditions within a time limit, and submit subsequent research results in a timely manner.
Source: Website of the State Drug Administration
- END -
The epidemic defense line is densely woven!The meeting of the leading group of the new coronary pneumonia epidemic prevention and control work was held
On July 18, Chen Jie, the secretary of the district committee, presided over a mee...
Tax and benefit children's family
On March 19 this year, the State Council made a decision to set up special additional deductions for personal income tax for infants and young children under the age of 3. In order to allow the person